Longview Partners’s CME Group CME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$300M Sell
1,016,950
-369,818
-27% -$110M 4.26% 14
2025
Q4
$379M Buy
+1,386,768
New +$377M 3.95% 17

Other funds holding CME

Longview Partners's CME Position: Q1 2026 in Review

Longview Partners reduced its CME Group (CME) stake by 27% in Q1 2026, selling an estimated $110M and leaving 1,016,950 shares worth $300M. The position accounts for 4.26% of the portfolio, ranked #14.

Longview Partners first reported a position in CME in Q4 2025 and has held it in 2 quarters since. The position peaked at $379M in Q4 2025. 1,790 funds tracked by Wall St. Rank hold CME as of Q1 2026.

  • Longview Partners held 1,016,950 shares of CME Group worth $300M as of Q1 2026.
  • Longview Partners sold 369,818 CME Group shares in Q1 2026, an estimated $110M.
  • CME Group made up 4.26% of Longview Partners's portfolio in Q1 2026, its #14 holding.
  • Longview Partners first reported a position in CME Group in Q4 2025 and has held it in 2 quarters since.
  • Longview Partners's CME Group position peaked at $379M in Q4 2025.
  • 1,790 funds tracked by Wall St. Rank held CME Group as of Q1 2026.

Based on Longview Partners's 13F filing for Q1 2026, filed 15 May 2026.